Selective degradation of ARID1B achieved. Earlier this year, Foghorn announced that the company has achieved selective degradation of ARID1B and will provide a program update during 2025.
The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...
As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.
Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.
3h
Study Finds on MSNAspirin FTW! Common painkiller could be an anti-cancer allyIn a nutshell Aspirin may help prevent cancer from spreading by stopping platelets from producing thromboxane A2 (TXA2), ...
The Queen’s Advanced Lung Institute will feature a team of expert health care providers focused on providing high quality care and early diagnosis of lung cancer for patients.
In 1985 and 86, as 54-year-old filmmaker Andrei Tarkovsky was dying of lung cancer, he managed to complete The Sacrifice, one ...
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...
Deborah Stahlnecker, DO, who specializes in pulmonology and critical care medicine, talks about innovative ways St. Luke’s diagnoses and treats patients with asthma, COPD and lung cancer on this Commu ...
Discover essential steps to protect and strengthen your lungs, from quitting smoking to breathing exercises that can ...
The Seneca Lake Guardian has reported that Tuesday night’s vote to approve the agreement and permit has been deemed invalid ...
On his 59th birthday, Guy Jacobson received the ultimate gift—a second chance at life through a double lung transplant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results